Posted in Regulatory Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings April 24, 2026 Pharmaceutical Technology The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases. RegulatoryRead full story